"Ziekenhuis Rivierenland biedt medisch specialistische zorg en expertise in de regio en draagt daarmee bij aan positieve gezondheid. Bij Ziekenhuis Rivierenland voelt u zich veilig & vertrouwd."

During the past decade, Ziekenhuis Rivierenland conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ziekenhuis Rivierenland" #1 sponsor was "Kowa Research Europe" with 4 trials, followed by "Borstkanker Onderzoek Groep" with 3 trials sponsored, "Radboud University Medical Center" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ziekenhuis Rivierenland" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 3 trials as a collaborator, "Agendia" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator and "BOOG Study Center" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Ziekenhuis Rivierenland" are "Cardiovascular Disease" (2 trials), "Colorectal Cancer" (2 trials), "Dyslipidemia" (2 trials), "Hypercholesterolemia" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Ziekenhuis Rivierenland" in a lesser frequency.

Most popular intervention types in "Ziekenhuis Rivierenland" are "Drug" (14 trials), "Other" (4 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Pitavastatin" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Atorvastatin" (1 trials) and "CDK 4/6 inhibitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ziekenhuis Rivierenland" are 22 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ziekenhuis Rivierenland". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Ziekenhuis Rivierenland, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ziekenhuis Rivierenland, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".